We are pleased to invite investors and analysts to participate in our virtual event on Friday, 29 May 2020, highlighting Roche data accepted for presentation via the ASCO20 Virtual Scientific Program May 29-31, 2020.
17:00 – 18:15 CEST / 16:00 - 17:15 BST
11:00 – 12:15 am EDT / 8:00 - 9:15 am PDT
The event will start with a presentation, followed by a Q&A session (live access to the speakers).
Speakers:
Ira Mellman, Vice President, Cancer Immunology, Genentech Research and Early Development
Alan Sandler, M.D., Global Head of Product Development - Solid Tumors
Access to live event
Please pre-register for our webinar here.*
A replay of the webcast will be available via ir.roche.com
get the latest news and updates to your inbox.